OPC Pharmaceutical JSC

OPC Pharmaceutical JSC EBIT Margin

The EBIT Margin (Operating Margin) of OPC Pharmaceutical JSC (OPC.VN) as of Nov 4, 2026 is 13.19 %. In the previous year, EBIT Margin (Operating Margin) was 13.85 % — a change of -4.76% (lower).

EBIT Margin

13.19 %

YoY

-4.76%

Last updated:

EBIT Margin (Operating Margin) of OPC Pharmaceutical JSC is 2024 13.19 % . EBIT Margin (Operating Margin) of OPC Pharmaceutical JSC was 2023 13.85 % . It decreases by -4.76% lower compared to the previous year.

For OPC Pharmaceutical JSC, the operating (EBIT) margin of 13.2% is broadly stable versus 12.4% a few years ago.

The OPC Pharmaceutical JSC EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2013
0.15 VND
Jan 1, 2014
14.19 VND
Jan 1, 2015
13.67 VND
Jan 1, 2016
12.43 VND
Jan 1, 2017
11.70 VND
Jan 1, 2018
11.59 VND
Jan 1, 2023
13.85 VND
Jan 1, 2024
13.19 VND
The OPC Pharmaceutical JSC EBIT Margin history
YEAREBIT MarginYoY
13.19 %-4.76%
13.85 %+19.43%
11.59 %-0.92%
11.70 %-5.84%
12.43 %-9.09%
13.67 %-3.68%
14.19 %+9,440.18%
0.15 %-16.07%
0.18 %-8.54%
0.19 %+13.43%
0.17 %+23.90%
0.14 %-13.19%
0.16 %-18.12%
0.19 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

OPC Pharmaceutical JSC Stock analysis

What does OPC Pharmaceutical JSC do? OPC Pharmaceutical JSC manufactures and markets pharmaceutical products derived from natural materials cultivated and processed at its facilities. The company produces and trades pharmaceutical chemicals and supplies, functional food, wine, and bottled water. Its primary revenue streams include the sale of manufactured drugs, pharmaceutical chemicals, and functional food to healthcare providers and consumers. The company also engages in wholesale trading of pharmaceutical products and supplies. OPC Pharmaceutical JSC's product portfolio includes drugs made from natural pharmaceutical materials, pharmaceutical chemicals, functional food, wine, and bottled water. The company markets these products through its own distribution channels, targeting both medical institutions and end consumers. The firm's operations in wine distillery and bottled water manufacturing complement its pharmaceutical business, providing additional revenue streams. The company's manufacturing and marketing activities focus on natural pharmaceutical materials, pharmaceutical chemicals, and functional food. Its sales are directed towards healthcare providers for drug distribution and to consumers for functional food, wine, and bottled water. The dissolution of OPC EXIM Real Estate Joint Stock Company in 2014 does not affect its core pharmaceutical and related product lines. OPC Pharmaceutical JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about OPC Pharmaceutical JSC stock

EBIT Margin (Operating Margin) of OPC Pharmaceutical JSC is 13.19 % in 2024.

EBIT Margin (Operating Margin) of OPC Pharmaceutical JSC changed from 13.85 % to 13.19 %, representing a -4.76% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) OPC Pharmaceutical JSC since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s OPC Pharmaceutical JSC with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — OPC Pharmaceutical JSC

All Key Metrics — OPC Pharmaceutical JSC